arrow
M

Melanie Powell

Barts and The London NHS Trust
H指数:40
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations

子宫内膜癌中的沙漠免疫表型:一个具有不良预后和可靶向突变的独特亚群

2026-04-100
OAAI
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial

高危子宫内膜癌患者中辅助放化疗与单纯放疗的比较(PORTEC-3):一项随机III期试验的10年临床结局及基于分子分型的事后分析

2025-09-050
OAAI
Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma: Histologic and Clinicopathological Correlates

p53异常子宫内膜癌中的视网膜母细胞瘤蛋白丢失: 组织学和临床病理相关性

2025-03-010
OAAI
Prediction of recurrence risk in endometrial cancer with multimodal deep learning

多模态深度学习预测子宫内膜癌复发风险

2024-05-244
OAAI
Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts
2023-02-0133
OAAI
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
2023-01-2373
OAAI
Endometrial cancer

子宫内膜癌

LANCET
IF88.5
2022-04-01558
OAAI
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

三级淋巴结构对子宫内膜癌患者的预后至关重要

2022-03-1673
OAAI
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
2022-02-0114
OAAI
Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer
2021-03-0838
OAAI
Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
2021-03-0124
OAAI
NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update
2021-02-0191
OAAI
Patterns of Recurrence and Survival in the Randomized Portec-3 Trial of Chemoradiotherapy for High-Risk Endometrial Cancer
2019-09-010
OAAI
Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative
2018-12-0139
OAAI